CoChat

GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration

Open access
Ackeifi, Courtney, Wang, Peng, Karakose, Esra, Manning Fox, Jocelyn E., González, Bryan J., Liu, Hongtao, Wilson, Jessica, Swartz, Ethan, Berrouet, Cecilia, Li, Yansui, Kumar, Kunal, MacDonald, Patrick E., Sanchez, Roberto, Thorens, Bernard, DeVita, Robert, Homann, Dirk, Egli, Dieter, Scott, Donald K., Garcia-Ocaña, Adolfo, Stewart, Andrew F. · 2020 · Science Translational Medicine
Cited by 125

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

GLP-1 receptor agonists, widely used to treat diabetes, are converted to human β cell regenerative drugs by adding a DYRK1A inhibitor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaw9996

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 125

Metadata

Authors
Ackeifi, C., Wang, P., Karakose, E., Manning Fox, J. E., González, B. J., Liu, H., Wilson, J., Swartz, E., Berrouet, C., Li, Y., Kumar, K., MacDonald, P. E., Sanchez, R., Thorens, B., DeVita, R., Homann, D., Egli, D., Scott, D. K., Garcia-Ocaña, A., & Stewart, A. F.
Venue
Science Translational Medicine
Published
2020-02-12
Volume
12
Issue
530
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W3005696213
Cited by
125
References
9
FWCI
16.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration. https://app.cochat.ai/papers/10.1126/scitranslmed.aaw9996
The paper
Ackeifi, C., Wang, P., Karakose, E., Manning Fox, J. E., González, B. J., Liu, H., Wilson, J., Swartz, E., Berrouet, C., Li, Y., Kumar, K., MacDonald, P. E., Sanchez, R., Thorens, B., DeVita, R., Homann, D., Egli, D., Scott, D. K., Garcia-Ocaña, A., & Stewart, A. F. (2020). GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaw9996

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.